Fatty liver disease, a growing global health concern, may have a new, inexpensive treatment option. A recent study identified ...

Researchers identified microRNA-93 as a genetic driver of fatty liver disease and showed that vitamin B3 can effectively suppress it. This breakthrough suggests niacin could be repurposed as a ...

The HATS study, conducted by Brown and colleagues, showed that simvastatin–niacin combination therapy provided a large reduction in cardiovascular risk compared with placebo. [4] The small population ...

Researchers found that vitamin B3 (niacin) can suppress miR-93, a key driver of fatty liver disease. In mice, niacin restored ...